Ardent Health Adds Missouri Hospital System in $47 Million Boone Health Deal
Ardent will pay $47 million in cash for Boone Health, a system with about $480 million in annual revenue, and commit $200 million over 10 years. The stock closed down 2.8% before the announcement.

Ardent Health, Inc. (NYSE: ARDT) said Thursday it has agreed to acquire Boone Health, a not-for-profit health system in Columbia, Missouri, for $47 million in cash. The company filed its 8-K at 4:16 p.m. ET on Nov. 12, after the regular session closed. Closing is expected in the first quarter of 2027, once the usual conditions are met.
A small cash price for a system with $480 million in revenue
The $47 million price is small next to Ardent's market value of about $2.48 billion. The company's earnings targets for the deal, which arrive in year three, carry more weight than the price. Ardent said Boone generated roughly $480 million of revenue in 2025. Because the regular session ended before the news, any read on the stock is provisional.
The stock fell before the news, and after-hours has barely traded
Ardent shares closed at $17.68 on Thursday, down 2.8% from Wednesday's close of $18.19. The drop came during the regular session, so the deal could not have caused it. The stock traded between $17.51 and $18.35 that day.
Regular-session volume was 525,809 shares, about half the 10-day average of 1,164,849. In after-hours trading (the session after the 4 p.m. close), the stock was unchanged at $17.68 on 9,373 shares through 4:15 p.m., a minute before the filing.
Over the period from Oct. 14 through Nov. 11, the shares rose 52.22%, from a low of $11.55 on Oct. 14 to a high of $18.57 on Nov. 9. The biggest day was Nov. 5, a gain of 22.4% to $15.90, one day after Ardent filed its quarterly results. Closes since then were $17.30, $17.97, $17.93 and $18.19.
What Ardent is getting and promising
Ardent is taking over Boone Hospital Center, which has 392 beds, along with Boone Health Medical Group, 19 care sites, related ancillary services and real estate. Boone's boards began a search for a strategic partner in 2025, and Ardent was chosen after a process led by an independent advisory firm, according to the release. The company said the deal gives it a presence in Missouri for the first time.
Under the agreement, Ardent committed to:
- $200 million in capital over 10 years, to pay for equipment, renovations, new facilities, hiring physicians and information systems. Near-term spending goes first to expanding the emergency department and modernizing operating rooms.
- Continued employment for all active Boone employees, physicians and advanced practice providers in good standing.
- A local advisory board for the hospital and continuation of its charity care policy.
Earnings targets arrive in year three
Ardent said it expects the deal to be modestly accretive to Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, adjusted by the company) in year one. The company expects accretion of 6% to 8% in year three. It also expects integration synergies, meaning cost savings and efficiencies from combining operations, to reach at least $30 million in year three.
Chief executive Dave Caspers said the agreement "advances our disciplined capital allocation strategy." The company described Boone as a mid-sized market with a growing population and a regional referral network.
What to watch next
- 5 p.m. ET on Nov. 12: Ardent's conference call and webcast on the transaction.
- Friday, Nov. 13: the first regular session after the announcement.
- First quarter of 2027: expected closing, subject to customary conditions.
Bottom line
Ardent is paying a modest cash price for a Missouri system with about $480 million in revenue, and it is committing $200 million over 10 years to invest in it. The company's accretion and synergy targets run to year three, and the stock has yet to trade on the news.
This article was processed by WSN Finance AI Analysis and prepared by WSN Editors based on financial analysis.
This article is for informational purposes only and is not investment advice.




